第一个三个月的高甘油三糖指数预测了不良的妊娠结果:一项回顾性队列研究
Songhong Song1,2,3, Qi Luo4, Xinyang Zhong1,3
1Department of Preventive Medicine, Shantou University Medical College, Shantou, China.
Archives of gynecology and obstetrics
|February 26, 2025
概括
一个升高的第一季度甘油三糖 (TyG) 指数与妊娠糖尿病 (GDM),孕前 (PE),妊娠高血压 (GH) 和早产的风险增加有关. 该指数显示了早期识别高风险怀孕的潜力.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 孕产妇和胎儿医学 孕产妇和胎儿医学
背景情况:
- 第一季度甘油三糖指数 (TyG) 与妊娠糖尿病 (GDM) 以及其他不良妊娠结果之间的关联需要进一步阐明.
- 这项研究调查了第一季度TyG指数对孕妇队列中不良妊娠结果的预测价值.
研究的目的:
- 检查第一个三个月的TyG指数与发展GDM,孕前 (PE),妊娠高血压 (GH) 和早产风险之间的关系.
- 评估TyG指数作为潜在的早期查工具,以检测不良妊娠结果.
主要方法:
- 这是一项追溯性队列研究,涉及11,942名孕妇.
- 使用第一季度的甘油三和禁食血糖水平计算TyG指数.
- 用多变量回归,子组,相互作用,调解和ROC曲线分析来评估关联和预测值.
主要成果:
- 第一季度TyG指数升高与GDM (或每单位增加2.21),PE (或2.89),GH (或1.47) 和早产 (或1.75) 的风险增加显著相关.
- GDM和PE部分调解了TyG指数和早产之间的关联.
- 泰格指数显示了GDM,PE,GH和早产的显著预测性能,结合的预测模型显示了更好的准确性.
结论:
- 一个较高的第一季度TyG指数是GDM,PE,GH和早产的重要风险因素.
- 泰格指数作为一个有价值和有前途的生物标志物,用于早期识别有不良妊娠结果风险的孕妇.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Pathophysiology of Diabetes
842
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
842
Glucose Transporters
22.4K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.4K
Oral Hypoglycemic Agents: Biguanides and Glitazones
152
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
152
Diabetes: Symptoms, Diagnosis, and Complications
495
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
495
Overview of Lipid Metabolism
930
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
930


